Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 213

1.

Effect of intravitreal methotrexate and aqueous humor cytokine levels in refractory retinal vasculitis in Behcet disease.

Bae JH, Lee SC.

Retina. 2012 Jul;32(7):1395-402. doi: 10.1097/IAE.0b013e31823496a3.

PMID:
22012204
2.

Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.

Taylor SR, Habot-Wilner Z, Pacheco P, Lightman SL.

Ophthalmology. 2009 Apr;116(4):797-801. doi: 10.1016/j.ophtha.2008.10.033.

PMID:
19344827
3.

Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease.

Tabbara KF, Al-Hemidan AI.

Am J Ophthalmol. 2008 Dec;146(6):845-50.e1. doi: 10.1016/j.ajo.2008.09.010.

PMID:
18929351
4.

Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema.

Roh MI, Kim HS, Song JH, Lim JB, Kwon OW.

Ophthalmology. 2009 Jan;116(1):80-6. doi: 10.1016/j.ophtha.2008.09.036.

PMID:
19118699
5.

Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.

Funk M, Karl D, Georgopoulos M, Benesch T, Sacu S, Polak K, Zlabinger GJ, Schmidt-Erfurth U.

Ophthalmology. 2009 Dec;116(12):2393-9. doi: 10.1016/j.ophtha.2009.05.039.

PMID:
19815292
6.

Multivariate analyses of inflammatory cytokines in eyes with branch retinal vein occlusion: relationships to bevacizumab treatment.

Kaneda S, Miyazaki D, Sasaki S, Yakura K, Terasaka Y, Miyake K, Ikeda Y, Funakoshi T, Baba T, Yamasaki A, Inoue Y.

Invest Ophthalmol Vis Sci. 2011 May 6;52(6):2982-8. doi: 10.1167/iovs.10-6299.

PMID:
21273540
7.

Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization.

Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N.

Retina. 2011 May;31(5):871-9. doi: 10.1097/IAE.0b013e3182003ca8.

PMID:
21358461
8.

Intraocular cytokine environment in active Behçet uveitis.

Ahn JK, Yu HG, Chung H, Park YG.

Am J Ophthalmol. 2006 Sep;142(3):429-34.

PMID:
16935587
9.

Profile of intraocular immune mediators in patients with age-related macular degeneration and the effect of intravitreal bevacizumab injection.

Agawa T, Usui Y, Wakabayashi Y, Okunuki Y, Juan M, Umazume K, Kezuka T, Takeuchi M, Yamauchi Y, Goto H.

Retina. 2014 Sep;34(9):1811-8. doi: 10.1097/IAE.0000000000000157.

PMID:
24801651
10.

Aqueous humor and plasma levels of vascular endothelial growth factor and interleukin-8 in patients with central serous chorioretinopathy.

Lim JW, Kim MU, Shin MC.

Retina. 2010 Oct;30(9):1465-71. doi: 10.1097/IAE.0b013e3181d8e7fe.

PMID:
20526231
11.

Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system.

Kang HM, Lee SC.

Graefes Arch Clin Exp Ophthalmol. 2014 Jun;252(6):1001-8. doi: 10.1007/s00417-014-2637-z.

PMID:
24796770
12.

Intravitreal infliximab for sight-threatening relapsing uveitis in Behçet disease: a pilot study in 15 patients.

Markomichelakis N, Delicha E, Masselos S, Sfikakis PP.

Am J Ophthalmol. 2012 Sep;154(3):534-541.e1. doi: 10.1016/j.ajo.2012.03.035.

PMID:
22789563
13.

[Diagnosis and treatment of eye diseases associated with HIV infection and AIDS].

Geng S, Ye JJ, Liu LQ, Xu HY, Wang WW, Wang SR.

Zhonghua Yan Ke Za Zhi. 2009 Dec;45(12):1093-8. Chinese.

PMID:
20193432
14.

Concentration of cytokines in the aqueous humor of patients with central serous chorioretinopathy.

Shin MC, Lim JW.

Retina. 2011 Oct;31(9):1937-43. doi: 10.1097/IAE.0b013e31820a6a17.

PMID:
21478806
15.

Cytokines, chemokines and soluble adhesion molecules in aqueous humor of children with uveitis.

Sijssens KM, Rijkers GT, Rothova A, Stilma JS, Schellekens PA, de Boer JH.

Exp Eye Res. 2007 Oct;85(4):443-9.

PMID:
17662277
16.

Correlation between Fluorescein Angiographic Findings and Visual Acuity in Behçet Retinal Vasculitis.

Kim M, Kwon HJ, Choi EY, Kim SS, Koh HJ, Lee SC.

Yonsei Med J. 2015 Jul;56(4):1087-96. doi: 10.3349/ymj.2015.56.4.1087.

17.

Intravitreal steroids may facilitate treatment of Eales' disease (idiopathic retinal vasculitis): an interventional case series.

Ishaq M, Feroze AH, Shahid M, Baig MA, Ameen SS, Feroze SH, Chishti RA.

Eye (Lond). 2007 Nov;21(11):1403-5.

PMID:
16980931
18.
19.

Intravitreal ranibizumab (Lucentis) for branch retinal vein occlusion-induced macular edema: nine-month results of a prospective study.

Rouvas A, Petrou P, Ntouraki A, Douvali M, Ladas I, Vergados I.

Retina. 2010 Jun;30(6):893-902. doi: 10.1097/IAE.0b013e3181cd4894.

PMID:
20531142
20.

Intravitreal cortisone injection for refractory diffuse diabetic macular edema.

Er H, Yilmaz H.

Ophthalmologica. 2005 Nov-Dec;219(6):394-400.

PMID:
16286802

Supplemental Content

Support Center